Prescription drug · BLA
Abrilada (Adalimumab-afzb) NDC 50090-8032
Kit · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-8032-0 | 50090803200 | 1 KIT in 1 KIT (50090-8032-0) * 1 SYRINGE in 1 TRAY / .8 mL in 1 SYRINGE (0025-0317-01) * 1 mL in 1 PACKET (0069-1111-01)Marketed from Aug 5, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Abrilada
- Generic name (nonproprietary)
- adalimumab-afzb
- Dosage form
- Kit
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 761118
- Marketing start
- Listing expires
- Identifiers
- Product ID 50090-8032_5447572d-c9f1-4a27-97c9-7f531f5557e3SPL ID 5447572d-c9f1-4a27-97c9-7f531f5557e3SPL set ID 1602cfaf-9ddd-4eb6-b847-10a4eebcf5e5RxCUI 797544, 2668074, 2668078
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N450090803200followed by a unit qualifier and the quantityPackage 50090-8032-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
ABRILADA is a tumor necrosis factor (TNF) blocker indicated for: • Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active rheumatoid arthritis . ( 1.1 ) • Reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis in patients 2 years of age and older. ( 1.2 ) • Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active psoriatic arthritis . ( 1.3 ) • Reducing signs and symptoms in adult patients with active ankylosing spondylit…
Excerpt only. Read the full label for complete information.
About NDC 50090-8032
- What is NDC 50090-8032?
- 50090-8032 is the product NDC for Abrilada (adalimumab-afzb) kit, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Abrilada (Adalimumab-afzb).
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Abrilada?
- 4 other product NDCs are listed under this name. See all Abrilada NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Abrilada products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Abriladaadalimumab-afzb | — | Kit | A-S Medication Solutions | 50090-7998 | 50090-7998-00 |
| Abriladaadalimumab-afzb | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0025-0328 | 00025-0328-02 |
| Abriladaadalimumab-afzb | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0025-0333 | 00025-0333-02 |
| Abriladaadalimumab-afzb | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0025-0325 | 00025-0325-0100025-0325-02 |
Other NDCs under BLA 761118
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Abriladaadalimumab-afzb | — | Kit | A-S Medication Solutions | 50090-7998 |
| Abriladaadalimumab-afzb | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0025-0328 |
| Abriladaadalimumab-afzb | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0025-0333 |
| Abriladaadalimumab-afzb | — | Kit | Pfizer Laboratories Div Pfizer Inc | 0025-0325 |